Disclosures for "Real-world Delays in Anti-amyloid Therapy Initiation Following Diagnosis of Early-stage Alzheimer’s Disease"
-
Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Esai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai.
-
Dr. Singh has nothing to disclose.
-
Mrs. Schnee has nothing to disclose.